Anupam Rasayan India Limited IPO (Anupam Rasayan IPO) Detail

Anupam Rasayan Company Details:
Anupam Rasayan isone of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India .It commenced business as a partnership firm in 1984 as a manufacturer of conventional products and have, over the years, evolved into custom synthesis and manufacturing of life science related specialty chemicals and other specialty chemicals, which involve multi-step synthesis and complex
technologies, for a diverse base of Indian and global customers. Its key focus in its custom synthesis and manufacturing operations is developing in-house innovative processes for manufacturing products requiring complex chemistries and achieving cost optimization.

It has two distinct business verticals (i) life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and (ii) other specialty chemicals, comprising specialty pigment and dyes, and polymer additives. In Fiscal 2020 and in the six months ended September 30, 2020, revenues from its life science related specialty chemicals vertical accounted for 95.37% and 92.48%, respectively, of its revenue from operations, while revenue from other specialty chemicals accounted for 4.63% and 7.52%, respectively, of its revenue from operations, in such periods.
According to the F&S Report, there exist significant entry barriers in the custom synthesis and manufacturing industry including customer validation and approvals, high quality standards, stringent specifications, and expectation from customers for process innovation and cost reduction. Further, the acquisition of a customer is a long process since the end-customer is required to register the manufacturer with the regulatory bodies as a supplier of intermediate products or active ingredients (Source: F&S Report).

Anupam Rasayan has developed strong and long-term relationships with various multinational corporations, including, Syngenta Asia Pacific Pte. Ltd., Sumitomo Chemical Company Limited and UPL Limited that has helped us expand our product offerings and geographic reach across Europe, Japan, United States and India. In particular, it has been manufacturing products for certain customers for over 10 years. In the six months ended September 30, 2020, it manufactured products for over 45 domestic and international customer, including 15 multinational companies. The Government of India has also recognized our Company as a three star export house We believe that our ability to meet stringent quality and technical specifications and customizations, undertake large number of complex chemical reactions and automated manufacturing capabilities, develop in-house innovative processes along with strong technical competencies and R&D capabilities, and transparent cost model, have enabled it to act as a complete one-stop solution for process innovation and development of specialty chemicals for multinational companies in a cost efficient manner. It is also one of the leading companies in manufacturing products using continuous and flow chemistry technology on a commercial scale in India (Source: F&S Report). The continuous process technology has distinct advantages over the traditional batch process, which is typically used by specialty chemical companies, in reducing the batch cycle time of a chemical production process and making the process safer and environment friendly as well as energy and cost efficient (Source: F&S Report).
Further, it has a dedicated in-house R&D facility and a pilot plant located at Sachin Unit – 6, which is equipped with laboratories engaged in process development, process innovation, new chemical screening and engineering, which assists it in pursuing efficiencies from the initial conceptualization up to commercialization of a product.
Its R&D team has successfully carried out multi-step synthesis and scale-up for several new molecules in the area of life sciences related specialty chemicals and other specialty chemicals, and as a result, expanded its commercialized product portfolio from 25 products in Fiscal 2018 to 34 products in Fiscal 2020 and 36 products in the six months September 30, 2020

Its total revenue have increased at a CAGR of 24.29% from Rs 3,491.82 million in Fiscal 2018 to Rs 5,393.87 million in Fiscal 2020, and was Rs 2,375.73 million and Rs 3,735.99 million in the six months ended September 30, 2019 and 2020, respectively. Its EBITDA for Fiscals 2018, 2019, 2020 and the six months ended September 30, 2019 and 2020 was Rs 745.07 million, Rs 921.74 million, Rs 1,348.96 million, Rs 575.40 million, Rs 774.00 million, respectively while its EBITDA margin was 21.82%, 18.38%, 25.51%, 24.55% and 21.79%, respectively, for similar periods.
Its profit after tax and share of profit of associates was Rs 413.07 million, Rs 492.48 million, Rs 529.75 million, Rs 217.39 million and Rs 264.83 million for Fiscals 2018, 2019, 2020 and the six months ended September 30, 2019 and 2020, respectively, while its PAT margin was 11.83%, 9.45%, 9.82%, 9.15% and 7.09%,

The strengths of the company:
* Strong and long-term relationships with diversified customers across geographies with significant entry barriers;
* Core focus on process innovation through consistent R&D, value engineering and complex chemistries;
* Diversified and customized product portfolio with a strong supply chain;
* Automated manufacturing facilities with strong focus on environment, sustainability, health and safety measures;
* Consistent track record of financial performance; and
* Experienced promoters and strong management team.
For more study : www.anupamrasayan.com

The promoters of Anupam Rasayan India Limited:
Mr. Anand S. Desai
Dr Kiran C. Patel
Ms. Mona A. Desai
Kiran Pallavi Investments LLC &
Rehash Industrial & Resins Chemicals Pvt ltd

Anupam Rasayan India Limited IPO Main Objects:
The Offer is of  Fresh Issue.
The Company proposes to utilise the Net Proceeds towards funding the following  main object:
Repayment/prepayment of certain indebtedness availed by the Company (including accrued interest)

Company Financials:

Anupam Rasayan IPO Date & Price Band:

Anupam Rasayan IPO Market Lot:

Anupam Rasayan IPO Allotment & Listing: